- May 6, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
etanercept-ykro, Erelzi, Eticovo, Enbrel, etanercept-szzs,
Synonyms :
Class :
Antirheumatics snd TNF alfa inhibitors
Brand Name :
etanercept-ykro, Erelzi, Eticovo, Enbrel, etanercept-szzs,
Synonyms :
Class :
Antirheumatics snd TNF alfa inhibitors
Dosage Forms & Strengths:
Solution
25 mg/0.5 mL (0.5 mL)
Solution Auto-injector
50 mg/mL (Enbrel SureClick)
Solution Cartridge
50 mg/mL (Enbrel Mini)
Solution Prefilled Syringe
25 mg/0.5 mL (Enbrel)
50 mg/mL (Enbrel)
Solution Reconstituted
25 mg (Enbrel)
Dosage Forms & Strengths:
Solution
25 mg/0.5 mL (0.5 mL)
Solution Auto-injector
50 mg/mL (Enbrel SureClick)
Solution Cartridge
50 mg/mL (Enbrel Mini)
Solution Prefilled Syringe
25 mg/0.5 mL (Enbrel)
50 mg/mL (Enbrel)
Solution Reconstituted
25 mg (Enbrel)
coccidioides immitis skin test
it may reduce the diagnostic effect of coccidioides immitis skin test
it may reduce the therapeutic effect of covid-19 vaccine (subunit)
it may increase the immunosuppressive effect of abatacept
it may increase the immunosuppressive effect of immunosuppressants
it may increase the risk of adverse effects of anakinra
it may increase the immunosuppressive effect of anifrolumab
it may increase the immunosuppressive effect of baricitinib
it may increase the risk of adverse effects of bcg products
it may increase the immunosuppressive effect of biologic disease-modifying antirheumatic agents
biologic disease modifying antirheumatic drugs (dmards)
it may increase the immunosuppressive effect of other biologic disease-modifying antirheumatic drugs
when both drugs are combined, there may be an increased metabolism of etoposide
when both drugs are combined, the metabolism of paclitaxel increases when compared with etanercept
when both the drugs are combined, the metabolism of carmustine increases
When both drugs are combined, there may be an increased risk or severity of adverse effects
when both drugs are combined, there may be an increased risk or severity of adverse effects
when both drugs are combined, there may be an increased risk or severity of adverse effects
when both drugs are combined, there may be an increased risk of severe and potentially life-threatening infections
when both drugs are combined, there may be an increased risk of severe and potentially life-threatening infections
when both drugs are combined, there may be an increased risk or severity of adverse effects
when both drugs are combined, there may be an increased risk or severity of adverse effects
interaction raises immunosuppressive effects and risk of infection
tumor necrosis factor (TNF) blocking agent may enhance the immunosuppressive effect of abatacept
may increase the immunosuppressive effect of abatacept
may increase the immunosuppressive effect of certolizumab pegol
it may reduce the therapeutic effect of brincidofovir
immunosuppressants (therapeutic immunosuppressant agents) may enhance the immunosuppressive effect of cladribine. risk x: avoid combination
both the drugs increase the effect of immunosuppression risk of infection increases on administering both the drugs simultaneously
tumor necrosis factor (TNF) blocking agent may enhance the immunosuppressive effect of anakinra
Adverse drug reactions:
Frequency Defined
>10%
Diarrhea (16%)
Rash (13%)
Infection (81%)
Upper respiratory infections (65%)
Injection site reactions (43%)
Non-upper respiratory infections (54%)
1-10%
Urticaria (2%)
Hypersensitivity (1%)
Pruritus (5%)
Pyrexia (2%)
Post marketing Reports
Pancytopenia
Leukopenia
Neutropenia
Thrombocytopenia
Lymphadenopathy
aplastic anemia
Congestive heart failure
Inflammatory bowel disease (IBD
Angioedema
Pregnancy warnings:
Pregnancy Category: N/A
Lactation: known
Pregnancy Categories:
Patient Information Leaflet
Generic Name: etanercept (Rx)
Why do we use etanercept (Rx)?
etanercept (Rx) belongs to the class of Antirheumatics, TNF alfa inhibitors which helps to treat plaque psoriasis, Alzheimer’s disease, and joint damage in ankylosing spondylitis, rheumatoid arthritis, psoriatic arthritis.